drugset / Trial / NCT01123538
Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile
RandomizedParallel-groupOpen-label
Summary
The purpose of this study is to compare combined postmenopausal hormone therapy natural progesterone to the one containing synthetic progestagen (i.e. chlormadinone acetate) at the blood transcriptome level.
Timeline
- Start
- 2008-12
- Primary completion
- 2011-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 200 mg | Oral |
| Comparator | chlormadinone acetate | Small molecule | 5 mg | Oral |
| Background | Estradiol | Other / unclassified | 0.05 mg | Other |
Indications
No indication recorded.